Mantle Cell Lymphoma Recurrent
5 clinical trials · Condition
◉ Watch Mantle Cell Lymphoma Recurrent
| Record | Firm | Date |
|---|---|---|
| Study to Assess Safety, Tolerability and Efficacy of MB-106 in Patients With Relapsed or Refractory B-Cell NHL or CLL (NCT05360238) | Mustang Bio | 2022-05-24 |
| Long-term Follow-up Study in Patients Previously Treated With a Mustang Bio CAR-T Cell Investigational Product. (NCT05645744) | Mustang Bio | 2021-09-29 |
| Clinical Trial to Assess The Efficacy and Safety of the Combination of Tisagenlecleucel And Ibrutinib in Mantle Cell Lymphoma (NCT04234061) | Peter MacCallum Cancer Centre, Australia | 2020-04-07 |
| A Phase II Study of Doxycycline in Relapsed NHL (NCT02086591) | University of Rochester | 2014-03-01 |
Track Mantle Cell Lymphoma Recurrent automatically
Every clearance here is in the API, with alerts when new ones post.